The analysis of surface markers on the DC population showed that VV-iPDL1/GM injection significantly increased tumor-infiltrating CD103+ DCs, compared to VV-GM or VV-RFP (Fig. 7c, Supplementary Fig. 13). This evidence concerns the gene ITGAE and neoplasm.